ArticleDrug design, development and therapy2019

Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways.

Haitao Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.